AI Generated Image
Millions of eye drops recalled. See impacted products
USA Today • • business
Key Points:
- Over 2.5 million bottles of Prednisolone Acetate Ophthalmic Suspension eye drops, manufactured by Lupin Pharmaceuticals Inc., have been recalled nationwide due to the potential presence of a foreign substance.
- The recall, initiated on June 4 and classified as a Class II recall on June 30, involves 5 mL, 10 mL, and 15 mL bottles labeled as "prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only."
- A Class II recall indicates that the product may cause temporary or medically reversible adverse health consequences if used or exposed to.
- Prednisolone eye drops are prescribed to treat mild to moderate non-infectious eye allergies, inflammation, and damage caused by chemical or thermal burns.
- The FDA advises individuals to immediately stop using the recalled eye drops and manufacturers to notify customers with instructions, though specific remedies for consumers were not detailed in the enforcement report.
